Mixed Q2 Earnings Highlight Divergent Performances Among U.S. Insurers
Explore the latest Q2 earnings results from major U.S. insurance companies, highlighting mixed performances amid evolving market dynamics and regulatory shifts.
Explore the latest Q2 earnings results from major U.S. insurance companies, highlighting mixed performances amid evolving market dynamics and regulatory shifts.
Sapiens releases Version 13.0 of CoreSuite for Property & Casualty, enhancing AI-driven underwriting, claims, and billing capabilities to optimize insurer operations in North America.
Westfield Insurance names Henning Haagen as Chief Underwriting Officer to lead enterprise underwriting strategy and portfolio management, enhancing underwriting performance and profitability.
Tesla Cybertruck drivers encounter increasing insurance cancellations due to high repair costs and limited production, while Tesla advances autonomous vehicle operations with new hires.
TransRe partners with Cytora to deploy AI-driven digital risk processing in facultative reinsurance, improving underwriting accuracy and operational efficiency.
American Integrity Insurance Group reports strong Q2 2025 financial results with significant policy growth and robust underwriting in Florida's residential property insurance market following its IPO.
Orion180 and Neural Earth collaborate to enhance wildfire risk underwriting using AI-powered geospatial analytics, improving precision and proactive risk management in homeowners insurance.
Explore how Healthy Paws and adoro Pet Insurance are driving growth and innovation in the expanding U.S. pet health insurance market, with key partnerships and new market entries enhancing coverage accessibility.
Swiss Re's August 2025 Life Guide update provides U.S. life insurers with new underwriting guidance on repurposed longevity drugs like metformin and rapamycin, enhancing risk assessment for evolving health trends.
Swiss Re updates its Life Guide to help underwriters assess life insurance risks related to repurposed longevity drugs like metformin and rapamycin, enhancing medical risk evaluation and underwriting consistency across global markets.